Open AccessEffect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia
Author(s) -
Lin-ling Cheng,
Wei-jie Guan,
Chong-yang Duan,
Nuo-fu Zhang,
Chun-liang Lei,
Yu Hu,
Ai-lan Chen,
Shi-yue Li,
Chao Zhuo,
Xi-long Deng,
Fan-jun Cheng,
Yong Gao,
Jian-heng Zhang,
Jiaxing Xie,
Hong Peng,
Ying-xian Li,
Xiao-xiong Wu,
Wen Liu,
Hui Peng,
Jian Wang,
Guangming Xiao,
Ping-Yan Chen,
Chunyan Wang,
Zi-feng Yang,
Jin-cun Zhao,
Nan-shan Zhong
Publication year - 2020
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2020.5503
Subject(s) - medicine , interquartile range , hazard ratio , gastroenterology , pneumonia , randomization , clinical trial , immunology , confidence interval
Lymphopenia is common and correlates with poor clinical outcomes in patients with coronavirus disease 2019 (COVID-19).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom